indomethacin

FDA Drug Profile — indomethacin, Indocin

indomethacin is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including indomethacin, Indocin. Available dosage forms: powder, capsule, extended release, suspension.

Drug details

Generic Name
indomethacin
Brand Names
indomethacin, Indocin
Application Number
ANDA203501
Sponsor
Hetero Drugs Limited
NDC Codes
5
Dosage Forms
POWDER, CAPSULE, EXTENDED RELEASE, SUSPENSION
Routes
ORAL
Active Ingredients
INDOMETHACIN

Indications and Usage

1 INDICATIONS AND USAGE Indomethacin extended-release capsules are indicated for: • Moderate to severe rheumatoid arthritis including acute flares of chronic disease • Moderate to severe ankylosing spondylitis • Moderate to severe osteoarthritis • Acute painful shoulder (bursitis and/or tendinitis) Indomethacin extended-release capsules are a nonsteroidal anti-inflammatory drug indicated for: • Moderate to severe rheumatoid arthritis including acute flares of chronic disease • Moderate to severe ankylosing spondylitis • Moderate to severe osteoarthritis • Acute painful shoulder (bursitis and/or tendinitis) ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.